Resilio Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Resilio Pharmaceuticals Private Limited

Resilio Pharmaceuticals Private Limited, a active private limited company, was established on 11 July 2018 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999TG2018PTC125588. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Khaja Rahmath Ali (Director), Sudheer Kumar Bashetty (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1-5-26/2/1, Maruthi Nagar Kothapet, Hyderabad, Telangana, 500060.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2018PTC125588

  • Registration Number

    125588

  • Incorporation Date

    11 July 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 229.22%
  • Profit Growth **** 136.19%
  • Ebitda **** 169.18%
  • Net Worth 129.07%
  • Total Assets **** 57.72%
Company report

Resilio Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Resilio Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Resilio Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Khaja Rahmath Ali Director 11 Jul 2018 Current
Sudheer Kumar Bashetty Director 11 Jul 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Resilio Pharmaceuticals.

Resilio Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 229.22% increase. The company also saw a substantial improvement in profitability, with a 136.19% increase in profit. The company's net worth Soared by an impressive increase of 129.07%.

Resilio Pharmaceuticals revenue growth over time
Resilio Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 229.22%
*******
*******
*******
*******
Revenue from Operations
*******
 229.14%
*******
*******
*******
*******
Total Assets
*******
 57.72%
*******
*******
*******
*******
Profit or Loss
*******
 136.19%
*******
*******
*******
*******
Net Worth
*******
 129.07%
*******
*******
*******
*******
EBITDA
*******
 169.18%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Resilio Pharmaceuticals?

In 2020, Resilio Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Resilio Pharmaceuticals?

Unlock and access historical data on people associated with Resilio Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Resilio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resilio Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Resilio Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Resilio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Resilio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Khaja Rahmath Ali was appointed as a Director was appointed as a Director on 11 Jul 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sudheer Kumar Bashetty was appointed as a Director was appointed as a Director on 11 Jul 2018 & has been associated with this company since 7 years 7 months . was documented.

  • Company Incorporation

    The activity Resilio Pharmaceuticals Private Limited was registered on 11 Jul 2018 with Roc Hyderabad & aged 7 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Resilio Pharmaceuticals Private Limited?

The CIN of Resilio Pharmaceuticals Private Limited is U74999TG2018PTC125588.

Where is Resilio Pharmaceuticals Private Limited headquartered?

Resilio Pharmaceuticals Private Limited is headquartered at 1-5-26/2/1, Maruthi Nagar Kothapet, Hyderabad, Telangana, 500060.

When was Resilio Pharmaceuticals Private Limited incorporated?

Resilio Pharmaceuticals Private Limited was incorporated on 11 July 2018.

Who are the current directors of Resilio Pharmaceuticals Private Limited?

The current directors of Resilio Pharmaceuticals Private Limited are

What is the primary industry of Resilio Pharmaceuticals Private Limited?

The primary industry of Resilio Pharmaceuticals Private Limited is Trade.

Is Resilio Pharmaceuticals Private Limited a listed company?

Resilio Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Resilio Pharmaceuticals Private Limited?

The authorized capital of Resilio Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available